Related Experiment Video
Updated: Jul 26, 2025

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
Serotonin syndrome-A focused review
Nicolaj Mikkelsen1,2, Per Damkier1,2, Sidsel Arnspang Pedersen1,2
1Department of Clinical Pharmacology, Odense University Hospital, Odense, Denmark.
Serotonin syndrome, a serious condition from excess serotonin receptor stimulation, is increasingly recognized. Early diagnosis and treatment of this potentially fatal drug toxicity are vital for patient outcomes.
Area of Science:
- Pharmacology
- Toxicology
- Clinical Medicine
Background:
- Serotonin syndrome is a potentially life-threatening condition resulting from overstimulation of serotonin receptors by serotonergic drugs.
- The increasing use of serotonergic medications, particularly selective serotonin reuptake inhibitors, likely contributes to a rise in serotonin syndrome cases.
- The exact incidence of serotonin syndrome is difficult to determine due to its varied clinical presentation.
Purpose of the Study:
- To offer a clinically oriented review of serotonin syndrome.
- To cover pathophysiology, epidemiology, clinical signs, diagnosis, differential diagnosis, and treatment.
- To classify serotonergic drugs and their mechanisms, emphasizing the pharmacological context for detection and management.
Main Methods:
- A focused literature review was conducted.
- The PubMed database was utilized for the literature search.
Main Results:
- Serotonin syndrome can arise from therapeutic use, overdose of a single drug, or interactions between multiple serotonergic agents.
- Key clinical features include neuromuscular excitation, autonomic dysfunction, and altered mental status.
- These symptoms typically appear in patients with recent changes in serotonergic drug therapy.
Conclusions:
- Early recognition and prompt treatment of serotonin syndrome are essential to minimize patient morbidity.
- Understanding the pharmacological basis is critical for managing this condition effectively.
More Related Videos
12:21Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram
Published on: November 27, 2016
07:30HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
Published on: July 9, 2016
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Antidepressant Drugs: Overview
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...